The influence of body mass index, basal FSH and age on the response to gonadotrophin stimulation in non-polycystic ovarian syndrome patients

Human Reproduction

Volumn 17, Issue 5, 2002, Pages 1207-1211

  Loh, Sheila ^a,b   Wang, Jim X ^a   Matthews, Colin D ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

Author keywords

Age; BMI; Controlled ovarian stimulation; FSH; Ovulation induction

Indexed keywords

CLOMIFENE CITRATE; FOLLITROPIN; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN;

ADULT; AGE; AGING; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONCEPTION; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; HUMAN; MAJOR CLINICAL STUDY; OVARY CYST; OVULATION INDUCTION; PREGNANCY; RISK ASSESSMENT; STIMULATION;

FALLOPIA;

EID: 0036107433     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.5.1207     Document Type: Article

References (17)

1. Basal estradiol and follicle-stimulating hormone predict fecundity in women of advanced reproductive age undergoing ovulation induction therapy
2. Relative influence of serum follicle stimulating hormone, age and other factors on ovarian response to gonadotrophin stimulation
3. Influence of weight in the induction of ovulation with human menopausal gonadotropin and human chorionic gonadotropin
4. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women
5. Anthropometric indicators and response to gonadotrophin for ovulation induction
6. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome
7. Follicle stimulating hormone levels on cycle day 3 predict ovulation stimulation response
8. Age related changes in the female reproductive cycle
9. Advances in induction of ovulation
10. Effect of body mass index and follicular synchrony in the ovarian response to ovulation induction with menotropins
11. Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization
12. Failure of body mass index or body weight to influence markedly the response to ovarian hyperstimulation in normal cycling women
13. Body weight, body mass index, and age: Predictors of menotropin dose and cycle outcome in polycystic ovarian syndrome?
14. Metabolic approaches to the subclassification of polycystic ovary syndrome
15. The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years
16. Adjuvant leuprolide in normal, abnormal, and poor responders to controlled ovarian hyperstimulation for in vitro fertilization/gamete intrafallopian transfer